688580 伟思医疗
已收盘 07-26 15:00:00
资讯
新帖
简况
伟思医疗07月25日主力资金流出20万元 连续7日减仓
自选股智能写手 · 07-25 15:18
伟思医疗07月25日主力资金流出20万元 连续7日减仓
伟思医疗（688580）7月24日主力资金净卖出107.60万元
证券之星 · 07-25 08:24
伟思医疗（688580）7月24日主力资金净卖出107.60万元
【机构调研记录】银华基金调研友发集团、伟思医疗等5只个股（附名单）
证券之星 · 07-25 08:01
【机构调研记录】银华基金调研友发集团、伟思医疗等5只个股（附名单）
【机构调研记录】格林基金调研伟思医疗
证券之星 · 07-25 08:01
【机构调研记录】格林基金调研伟思医疗
【机构调研记录】惠升基金调研伟思医疗、珠海冠宇
证券之星 · 07-25 08:01
【机构调研记录】惠升基金调研伟思医疗、珠海冠宇
【机构调研记录】大成基金调研伟思医疗、中旗新材等4只个股（附名单）
证券之星 · 07-25 08:01
【机构调研记录】大成基金调研伟思医疗、中旗新材等4只个股（附名单）
【机构调研记录】华宝基金调研恒帅股份、伟思医疗
证券之星 · 07-25 08:01
【机构调研记录】华宝基金调研恒帅股份、伟思医疗
【机构调研记录】中信保诚基金调研伟思医疗
证券之星 · 07-25 08:01
【机构调研记录】中信保诚基金调研伟思医疗
伟思医疗(688580.SH)：海外业务仍还在孵化中 暂时不会对公司业绩造成很大影响
格隆汇资讯 · 07-25 07:42
伟思医疗(688580.SH)：海外业务仍还在孵化中 暂时不会对公司业绩造成很大影响
伟思医疗：7月18日接受机构调研，中金医药、鹏华基金等多家机构参与
证券之星 · 07-24 17:16
伟思医疗：7月18日接受机构调研，中金医药、鹏华基金等多家机构参与
伟思医疗多个IPO募投项目频频变脸 延期后能否按期完成仍存悬念
每日经济新闻 · 07-21
伟思医疗多个IPO募投项目频频变脸 延期后能否按期完成仍存悬念
伟思医疗（688580）7月15日主力资金净卖出18.17万元
证券之星 · 07-16
伟思医疗（688580）7月15日主力资金净卖出18.17万元
伟思医疗07月11日遭主力抛售25万元 环比增加257.14%
自选股智能写手 · 07-11
伟思医疗07月11日遭主力抛售25万元 环比增加257.14%
伟思医疗新注册《Nd:YAG皮秒激光治疗仪软件V1》项目的软件著作权
证券之星 · 07-09
伟思医疗新注册《Nd:YAG皮秒激光治疗仪软件V1》项目的软件著作权
伟思医疗新提交5件商标注册申请
证券之星 · 07-08
伟思医疗新提交5件商标注册申请
7月4日伟思医疗跌5.03%，鑫元健康产业混合发起式A基金重仓该股
证券之星 · 07-04
7月4日伟思医疗跌5.03%，鑫元健康产业混合发起式A基金重仓该股
伟思医疗跌5.03%，西南证券二个月前给出“买入”评级，目标价54.05元
证券之星 · 07-04
伟思医疗跌5.03%，西南证券二个月前给出“买入”评级，目标价54.05元
伟思医疗07月04日遭主力抛售191万元 环比增加4675.00%
自选股智能写手 · 07-04
伟思医疗07月04日遭主力抛售191万元 环比增加4675.00%
伟思医疗大跌5.07% 7家券商给予增持建议
智选洞察 · 07-04
伟思医疗大跌5.07% 7家券商给予增持建议
伟思医疗（688580）7月3日主力资金净卖出3.88万元
证券之星 · 07-04
伟思医疗（688580）7月3日主力资金净卖出3.88万元
加载更多
公司概况
公司名称：
南京伟思医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2020-07-21
主营业务：
南京伟思医疗科技股份有限公司主营业务为医疗器械的研发、生产和销售，公司产品主要是MyOnyx生物刺激反馈仪、瑞翼生物刺激反馈仪、经颅磁刺激仪、盆底磁刺激仪、脉冲磁场治疗仪、脉冲磁恢复仪、脉冲磁塑形仪、多参数生物反馈仪、团体生物反馈仪、表面肌电分析系统、新生儿脑电测量仪、X-walk、X-locom、科瑞达钬激光治疗机、阴道电极、直肠电极、盆底训练探头、盆底肌肉康复器、认知功能障碍治疗软件、伟思云。
发行价格：
67.58
{"stockData":{"symbol":"688580","market":"SH","secType":"STK","nameCN":"伟思医疗","latestPrice":24.4,"timestamp":1721977200000,"preClose":24.28,"halted":0,"volume":419200,"delay":0,"floatShares":95771299,"shares":95771299,"eps":1.3358,"marketStatus":"已收盘","marketStatusCode":5,"change":0.12,"latestTime":"07-26 15:00:00","open":24.03,"high":24.66,"low":24.03,"amount":10211700,"amplitude":0.0259,"askPrice":24.4,"askSize":127,"bidPrice":24.33,"bidSize":4,"shortable":0,"etf":0,"ttmEps":1.3358,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722216600000},"adr":0,"adjPreClose":24.28,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721957400000,1721964600000],[1721970000000,1721977200000]],"highLimit":26.71,"lowLimit":21.85,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":95771288,"pbRate":1.42,"roa":"--","roe":"1.33%","epsLYR":1.9969,"committee":-0.083612,"marketValue":2337000000,"floatMarketCap":2337000000,"peRate":18.266207,"changeRate":0.0049,"turnoverRate":0.0044,"status":0,"afterMarket":{"amount":0,"volume":0,"close":24.4,"buyVolume":0,"sellVolume":0,"time":1721979237153,"indexStatus":"已收盘 07-26 15:30:00","preClose":24.28}},"requestUrl":"/m/hq/s/688580","defaultTab":"news","newsList":[{"id":"2454817407","title":"伟思医疗07月25日主力资金流出20万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2454817407","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454817407?lang=zh_cn&edition=full","pubTime":"2024-07-25 15:18","pubTimestamp":1721891934,"startTime":"0","endTime":"0","summary":"07月25日, 伟思医疗股价涨4.12%，报收24.28元，成交金额1798万元，换手率0.79%，振幅5.53%，量比1.90。伟思医疗今日主力资金净流出20万元，连续7日净流出，上一交易日主力净流出54万元，今日环比减少62.96%。近一年数据显示，该股主力连续7日净流出后，次日下跌概率为50.00%，平均跌幅为1.44%。该股近5个交易日下跌2.10%，主力资金累计净流出186万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出629万元，其中净流出天数为17日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407251530079ee8ecd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407251530079ee8ecd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2454866583","title":"伟思医疗（688580）7月24日主力资金净卖出107.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454866583","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454866583?lang=zh_cn&edition=full","pubTime":"2024-07-25 08:24","pubTimestamp":1721867087,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月24日收盘，伟思医疗报收于23.32元，下跌4.03%，换手率0.62%，成交量5934.0手，成交额1403.79万元。近5日资金流向一览见下表：伟思医疗融资融券信息显示，融资方面，当日融资买入272.5万元，融资偿还102.49万元，融资净买入170.01万元。伟思医疗主营业务：主要从事医疗器械的研发、生产和销售,以研发创新为发展驱动力,持续投入在电刺激、磁刺激、电生理、康复机器人以及医美能量源等方向的先进技术研发,并完善产品布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500013300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2454086390","title":"【机构调研记录】银华基金调研友发集团、伟思医疗等5只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2454086390","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454086390?lang=zh_cn&edition=full","pubTime":"2024-07-25 08:01","pubTimestamp":1721865706,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月24日披露的机构调研信息，银华基金近期对5家上市公司进行了调研，相关名单如下：1）友发集团 个股亮点：友发转债于2022-04-26上市；公司的产品焊接钢管在水利建设中有多种重要的应用；公司主要从事焊接圆管等焊接钢管产品的研发、生产和销售，可用于海绵城市建设2）伟思医疗 个股亮点：公司目前有部分产品应用于老年人康复治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500012742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0256","BK0251","688580","601686"],"gpt_icon":0},{"id":"2454863983","title":"【机构调研记录】格林基金调研伟思医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2454863983","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454863983?lang=zh_cn&edition=full","pubTime":"2024-07-25 08:01","pubTimestamp":1721865696,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月24日披露的机构调研信息，格林基金近期对1家上市公司进行了调研，相关名单如下：1）伟思医疗 个股亮点：公司目前有部分产品应用于老年人康复治疗。旗下最近一年表现最佳的公募基金产品为格林泓泰三个月定开债A，最新单位净值为1.02，近一年增长11.93%。旗下最新募集公募基金产品为格林聚利增强一个月持有期债券A，类型为债券型-混合二级，集中认购期2024年7月3日至2024年9月30日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500012725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2454863171","title":"【机构调研记录】惠升基金调研伟思医疗、珠海冠宇","url":"https://stock-news.laohu8.com/highlight/detail?id=2454863171","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454863171?lang=zh_cn&edition=full","pubTime":"2024-07-25 08:01","pubTimestamp":1721865692,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月24日披露的机构调研信息，惠升基金近期对2家上市公司进行了调研，相关名单如下：1）伟思医疗 个股亮点：公司目前有部分产品应用于老年人康复治疗。旗下最近一年表现最佳的公募基金产品为惠升领先优选混合A，最新单位净值为1.07，近一年增长7.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500012718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0224","688580","688772"],"gpt_icon":0},{"id":"2454863936","title":"【机构调研记录】大成基金调研伟思医疗、中旗新材等4只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2454863936","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454863936?lang=zh_cn&edition=full","pubTime":"2024-07-25 08:01","pubTimestamp":1721865683,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月24日披露的机构调研信息，大成基金近期对4家上市公司进行了调研，相关名单如下：1）伟思医疗 个股亮点：公司目前有部分产品应用于老年人康复治疗。大成基金成立于1999年，截至目前，资产管理规模3010.84亿元，排名31/204；资产管理规模2020.04亿元，排名25/204；管理公募基金数364只，排名17/204；旗下公募基金经理45人，排名21/204。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500012705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001212","688580","BK0251","BK0235"],"gpt_icon":0},{"id":"2454863195","title":"【机构调研记录】华宝基金调研恒帅股份、伟思医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2454863195","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454863195?lang=zh_cn&edition=full","pubTime":"2024-07-25 08:01","pubTimestamp":1721865674,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月24日披露的机构调研信息，华宝基金近期对2家上市公司进行了调研，相关名单如下：1）恒帅股份 个股亮点：公司ADAS主动感知清洗系统在未来高级别自动驾驶领域会有较好的市场前景。2）伟思医疗 个股亮点：公司目前有部分产品应用于老年人康复治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500012693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251","BK0264","300969"],"gpt_icon":0},{"id":"2454631168","title":"【机构调研记录】中信保诚基金调研伟思医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2454631168","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454631168?lang=zh_cn&edition=full","pubTime":"2024-07-25 08:01","pubTimestamp":1721865665,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月24日披露的机构调研信息，中信保诚基金近期对1家上市公司进行了调研，相关名单如下：1）伟思医疗 个股亮点：公司目前有部分产品应用于老年人康复治疗。旗下最近一年表现最佳的公募基金产品为中信保诚商品LOF，最新单位净值为0.67，近一年增长17.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500012680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580","LU1880383366.USD","LU0251144936.SGD","02378","BK1184","LU0048597586.USD"],"gpt_icon":0},{"id":"2454386386","title":"伟思医疗(688580.SH)：海外业务仍还在孵化中 暂时不会对公司业绩造成很大影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2454386386","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454386386?lang=zh_cn&edition=full","pubTime":"2024-07-25 07:42","pubTimestamp":1721864569,"startTime":"0","endTime":"0","summary":"格隆汇7月25日丨伟思医疗(688580.SH)近日在接待机构投资者调研时表示，海外市场是一个更为广阔的市场，公司对海外市场扩展长期保持积极态度，公司在2023年获得了塑形磁、盆底功能磁产品FDA认证，也陆续开始参与到一些国外的展会中。目前公司正加快海外市场注册取证、合规准入工作，同时开始搭建国际销售网络，促进企业的国际化发展。但短期来看，海外业务仍还在孵化中，暂时不会对公司业绩造成很大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250742549ee7adb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250742549ee7adb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2453076878","title":"伟思医疗：7月18日接受机构调研，中金医药、鹏华基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2453076878","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453076878?lang=zh_cn&edition=full","pubTime":"2024-07-24 17:16","pubTimestamp":1721812587,"startTime":"0","endTime":"0","summary":"答：公司2024年在售的光电类能量源设备主要包括私密电、私密磁、私密射频以及塑形磁。截至上半年，公司光电医美类产品已取得了可观的销售收入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072400039523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","688580","BK1574","BK1161","159938","BK0251","BK1515"],"gpt_icon":0},{"id":"2453244654","title":"伟思医疗多个IPO募投项目频频变脸 延期后能否按期完成仍存悬念","url":"https://stock-news.laohu8.com/highlight/detail?id=2453244654","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453244654?lang=zh_cn&edition=full","pubTime":"2024-07-21 13:27","pubTimestamp":1721539631,"startTime":"0","endTime":"0","summary":"与此同时，伟思医疗还将研发中心建设项目和信息化建设项目两个募投项目的达到预期可使用状态日期均由2022年9月调整至2023年9月。延期之后的募投项目能否按期完成？伟思医疗在2022年进行了变更的三个募投项目，在后续建设中仍迎来波折。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240721132736af933f7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240721132736af933f7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2451988152","title":"伟思医疗（688580）7月15日主力资金净卖出18.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451988152","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451988152?lang=zh_cn&edition=full","pubTime":"2024-07-16 08:21","pubTimestamp":1721089305,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月15日收盘，伟思医疗报收于24.79元，下跌3.99%，换手率0.41%，成交量3956.0手，成交额990.53万元。伟思医疗主营业务：主要从事医疗器械的研发、生产和销售,以研发创新为发展驱动力,持续投入在电刺激、磁刺激、电生理、康复机器人以及医美能量源等方向的先进技术研发,并完善产品布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600013210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2450438244","title":"伟思医疗07月11日遭主力抛售25万元 环比增加257.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450438244","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450438244?lang=zh_cn&edition=full","pubTime":"2024-07-11 15:19","pubTimestamp":1720682370,"startTime":"0","endTime":"0","summary":"07月11日, 伟思医疗股价涨3.98%，报收25.62元，成交金额1106万元，换手率0.45%，振幅2.72%，量比0.78。伟思医疗今日主力资金净流出25万元，连续7日净流出，上一交易日主力净流出7万元，今日环比增加257.14%。近一年数据显示，该股主力连续7日净流出后，次日下跌概率为66.67%，平均跌幅为1.44%。该股近5个交易日上涨2.81%，主力资金累计净流出239万元；近20日主力资金累计净流出446万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071115344695a47c3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071115344695a47c3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2450083045","title":"伟思医疗新注册《Nd:YAG皮秒激光治疗仪软件V1》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2450083045","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450083045?lang=zh_cn&edition=full","pubTime":"2024-07-09 01:22","pubTimestamp":1720459324,"startTime":"0","endTime":"0","summary":"证券之星消息，近日伟思医疗（688580）新注册了《Nd:YAG皮秒激光治疗仪软件V1》项目的软件著作权。今年以来伟思医疗新注册软件著作权6个，较去年同期增加了20%。结合公司2023年年报财务数据，2023年公司在研发方面投入了5765.42万元，同比增31.83%。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070900001539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2449710196","title":"伟思医疗新提交5件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2449710196","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449710196?lang=zh_cn&edition=full","pubTime":"2024-07-08 12:40","pubTimestamp":1720413632,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日南京伟思医疗科技股份有限公司新提交5件商标注册申请。商标申请详情如下：今年以来南京伟思医疗科技股份有限公司新申请注册商标6件，截止目前公司共持有注册商标320件，另有18件商标尚在注册申请中。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800011666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2448541434","title":"7月4日伟思医疗跌5.03%，鑫元健康产业混合发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448541434","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448541434?lang=zh_cn&edition=full","pubTime":"2024-07-04 16:21","pubTimestamp":1720081300,"startTime":"0","endTime":"0","summary":"证券之星消息，7月4日伟思医疗跌5.03%创60日新低，收盘报24.92元，换手率0.72%，成交量6899.0手，成交额1753.32万元。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为鑫元健康产业混合发起式A。鑫元健康产业混合发起式A目前规模为0.11亿元，最新净值0.7723，较上一交易日下跌1.39%，近一年下跌22.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400030677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2448241485","title":"伟思医疗跌5.03%，西南证券二个月前给出“买入”评级，目标价54.05元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448241485","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448241485?lang=zh_cn&edition=full","pubTime":"2024-07-04 16:21","pubTimestamp":1720081292,"startTime":"0","endTime":"0","summary":"今日伟思医疗跌5.03%，收盘报24.92元。2024年5月3日，西南证券研究员杜向阳发布了对伟思医疗的研报《23年业绩符合预期，24Q1短期承压》，该研报对伟思医疗给出“买入”评级，认为其目标价为54.05元，研报发布时股价为45.89元，预期涨幅为17.78%。考虑到公司在技术、产品、渠道、品牌和服务五方面的竞争优势，未来成长性突出，给予2024年23倍估值，对应目标价54.05元，维持“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400030674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","688580"],"gpt_icon":0},{"id":"2448415939","title":"伟思医疗07月04日遭主力抛售191万元 环比增加4675.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448415939","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448415939?lang=zh_cn&edition=full","pubTime":"2024-07-04 15:17","pubTimestamp":1720077471,"startTime":"0","endTime":"0","summary":"07月04日, 伟思医疗股价跌5.03%，报收24.92元，成交金额1753万元，换手率0.72%，振幅5.91%，量比2.08。伟思医疗今日主力资金净流出191万元，上一交易日主力净流出4万元，今日环比增加4675.00%。该股近5个交易日下跌7.81%，主力资金累计净流出214万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出392万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070415241395738b82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070415241395738b82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688580","BK0251"],"gpt_icon":0},{"id":"2448497171","title":"伟思医疗大跌5.07% 7家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2448497171","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448497171?lang=zh_cn&edition=full","pubTime":"2024-07-04 14:13","pubTimestamp":1720073619,"startTime":"0","endTime":"0","summary":"07月04日，伟思医疗股价大幅下跌，截至14点13分，伟思医疗下跌5.07%，报24.91元/股，创历史新低，成交1341万元，换手率0.55%，振幅5.83%。此外，数据统计显示，近半年内7家券商给予增持建议，8家券商给予买入建议。资金动向截止发稿，伟思医疗获得主力净流出171万元。最新财报显示，今年一季报，伟思医疗实现营业收入8,767.03万元，同比减少8.24%，净利润为2,175.32万元，同比减少27.69%，基本每股收益为0.32元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704141414aef7e6d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704141414aef7e6d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688580"],"gpt_icon":0},{"id":"2448457831","title":"伟思医疗（688580）7月3日主力资金净卖出3.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448457831","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448457831?lang=zh_cn&edition=full","pubTime":"2024-07-04 08:23","pubTimestamp":1720052631,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月3日收盘，伟思医疗报收于26.24元，下跌2.63%，换手率0.31%，成交量2936.0手，成交额777.59万元。伟思医疗主营业务：主要从事医疗器械的研发、生产和销售,以研发创新为发展驱动力,持续投入在电刺激、磁刺激、电生理、康复机器人以及医美能量源等方向的先进技术研发,并完善产品布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400011338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688580","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-07-21","address":"江苏省南京市雨花台区宁双路19号9栋","stockEarnings":[{"period":"1week","weight":-0.021},{"period":"1month","weight":-0.0845},{"period":"3month","weight":-0.1871},{"period":"6month","weight":-0.3091},{"period":"1year","weight":-0.4733},{"period":"ytd","weight":-0.4495}],"companyName":"南京伟思医疗科技股份有限公司","boardCode":"AI0035","perCapita":"18145股","boardName":"专用设备制造业","registeredCapital":"9577万元","compareEarnings":[{"period":"1week","weight":-0.0304},{"period":"1month","weight":-0.0214},{"period":"3month","weight":-0.0654},{"period":"6month","weight":-0.0081},{"period":"1year","weight":-0.1043},{"period":"ytd","weight":-0.0296}],"survey":" 南京伟思医疗科技股份有限公司主营业务为医疗器械的研发、生产和销售，公司产品主要是MyOnyx生物刺激反馈仪、瑞翼生物刺激反馈仪、经颅磁刺激仪、盆底磁刺激仪、脉冲磁场治疗仪、脉冲磁恢复仪、脉冲磁塑形仪、多参数生物反馈仪、团体生物反馈仪、表面肌电分析系统、新生儿脑电测量仪、X-walk、X-locom、科瑞达钬激光治疗机、阴道电极、直肠电极、盆底训练探头、盆底肌肉康复器、认知功能障碍治疗软件、伟思云。","serverTime":1721999923302,"listedPrice":67.58,"stockholders":"5278人(较上一季度减少0.92%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"伟思医疗,688580,伟思医疗股票,伟思医疗股票老虎,伟思医疗股票老虎国际,伟思医疗行情,伟思医疗股票行情,伟思医疗股价,伟思医疗股市,伟思医疗股票价格,伟思医疗股票交易,伟思医疗股票购买,伟思医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"伟思医疗(688580)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供伟思医疗(688580)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}